The DOI matches its Crossref record; 58 of the 60 references it cites were found in a registry or an index.
Which interventions offer best value for money in primary prevention of cardiovascular disease
Open accessAbstract
BACKGROUND: Despite many decades of declining mortality rates in the Western world, cardiovascular disease remains the leading cause of death worldwide. In this research we evaluate the optimal mix of lifestyle, pharmaceutical and population-wide interventions for primary prevention of cardiovascular disease. METHODS AND FINDINGS: In a discrete time Markov model we simulate the ischaemic heart disease and stroke outcomes and cost impacts of intervention over the lifetime of all Australian men and women, aged 35 to 84 years, who have never experienced a heart disease or stroke event. Best value for money is achieved by mandating moderate limits on salt in the manufacture of bread, margarine and cereal. A combination of diuretic, calcium channel blocker, ACE inhibitor and low-cost statin, for everyone with at least 5% five-year risk of cardiovascular disease, is also cost-effective, but lifestyle interventions aiming to change risky dietary and exercise behaviours are extremely poor value for money and have little population health benefit. CONCLUSIONS: There is huge potential for improving efficiency in cardiovascular disease prevention in Australia. A tougher approach from Government to mandating limits on salt in processed foods and reducing excessive statin prices, and a shift away from lifestyle counselling to more efficient absolute risk-based prescription of preventive drugs, could cut health care costs while improving population health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, legislation promoting a healthy lifestyle, such as reduced salt intake and smoking bans, are cost effective in preventing CVD. 18-22”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Law, M. R., Morris, J. K., & Wald, N. J. (2009) · BMJ · doi:10.1136/bmj.b1665 · Cited by 2,775 · cited 2×
“Newer evidence on drug efficacy [12,13], including alternative blood pressure-lowering drugs such as calcium channel blockers and ACE inhibitors, the changing price of statins [14–16], and increasing doubts about the use of aspirin in primary prevention [17,18], however, may mean that this is no longer the optimal str…”
BackgroundCardiovascular disease risk profiles
Anderson, K. M., Odell, P. M., Wilson, P. W. F., & Kannel, W. B. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90861-b · Cited by 2,163 · cited 1×
“We determine the probability of an event using the Framingham risk prediction equation [29].”
MethodMaking choices in health: who guide to cost-effectiveness analysis
(2004) · Revista Española de Salud Pública · doi:10.1590/s1135-57272004000300012 · Cited by 1,259
Law, M. R., Wald, N. J., Morris, J. K., & Jordan, R. E. (2003) · BMJ · doi:10.1136/bmj.326.7404.1427 · Cited by 1,232 · cited 2×
“Each cost is estimated as an average across the class, weighted by the mix of scripts provided in 2008 for an equivalent standard dose [38,39] (e.”
BackgroundLaw, M. R., Wald, N. J., & Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.308.6925.367 · Cited by 1,210 · cited 1×
“80% reduction in relative risk of stroke [13,50,51].”
BackgroundBrugts, J. J., Yetgin, T., Hoeks, S. E., Gotto, A. M., Shepherd, J., Westendorp, R. G. J., de Craen, A. J. M., Knopp, R. H., Nakamura, H., Ridker, P., et al. (2009) · BMJ · doi:10.1136/bmj.b2376 · Cited by 792 · cited 1×
“Newer evidence on drug efficacy [12,13], including alternative blood pressure-lowering drugs such as calcium channel blockers and ACE inhibitors, the changing price of statins [14–16], and increasing doubts about the use of aspirin in primary prevention [17,18], however, may mean that this is no longer the optimal str…”
BackgroundUnal, B., Critchley, J. A., & Capewell, S. (2004) · Circulation · doi:10.1161/01.cir.0000118498.35499.b2 · Cited by 739
Gold, M. R., Stevenson, D., & Fryback, D. G. (2002) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.23.100901.140513 · Cited by 652 · cited 1×
“these analyses, we base our results on health gain measured in DALYs, but since there is debate about when QALYs or DALYs are the superior measure [57], we also evaluate cost-effectiveness in QALYs to determine the impact (if any) of the QALY or DALY choice on cost-effectiveness results.”
Result
Research works printed but not linked: 1
- S Lim, 2005, Priority setting for the primary prevention of coronary heart disease and stroke in Australia [PhD thesis].
Cited by
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,334
“Despite limited evidence, these guidelines recommend a systematic approach to CV risk assessment targeting popula- tions likely to be at higher CV risk, such as those with a family history of premature CVD.”
InfluentialWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000596 · Cited by 1,127
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.037 · Cited by 486
The clinical consequences of an ageing world and preventive strategies
Lunenfeld, B., & Stratton, P. (2013) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2013.02.005 · Cited by 285
Systematic review of dietary salt reduction policies: Evidence for an effectiveness hierarchy?
Hyseni, L., Elliot-Green, A., Lloyd-Williams, F., Kypridemos, C., O’Flaherty, M., McGill, R., Orton, L., Bromley, H., Cappuccio, F. P., & Capewell, S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177535 · Cited by 278
F. Piepoli, M. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9583-6 · Cited by 162
“smoking habits is cost effective in preventing CVD [12, 13, 19].”
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0120 · Cited by 177
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Land, M., Webster, J. L., Christoforou, A., Praveen, D., Jeffery, P., Chalmers, J. P., Smith, W. T., Woodward, M., Barzi, F., Nowson, C. A., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-003720 · Cited by 118
“The level of excess salt consumption indicated by this survey would be anticipated to cause substantial disease burden in Australia leading both to large numbers of lives lost prematurely and to many individuals suffering significant disability.(17) With centrally managed salt reduction programmes projected to deliver…”
BackgroundFederici, C., Detzel, P., Petracca, F., Dainelli, L., & Fattore, G. (2019) · BMC Nutrition · doi:10.1186/s40795-018-0263-6 · Cited by 135
“82 g/day per person, mainly depending on the amount of nutrients reformulated, the spectrum of targeted foods and scenario studied [30, 36].”
BackgroundThe Efficacy and Tolerability of ‘Polypills’: Meta-Analysis of Randomised Controlled Trials
Elley, C. R., Gupta, A. K., Webster, R. J., Selak, V., Jun, M., Patel, A. A., Rodgers, A., & Thom, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052145 · Cited by 89
“[47] Modelled cost-effectiveness analyses of a ‘polypill’ have also been promising in middle and higher income countries.”
BackgroundAn effectiveness hierarchy of preventive interventions: neglected paradigm or self-evident truth?
Capewell, S., & CAPEWELL, A. E. (2017) · Journal of Public Health · doi:10.1093/pubmed/fdx055 · Cited by 103
Grimes, C. A., Kelley, S.-J., Stanley, S., Bolam, B., Webster, J. L., Khokhar, D., & Nowson, C. A. (2017) · BMC Public Health · doi:10.1186/s12889-017-4451-0 · Cited by 81
“salt content targets) in processed foods has been identified as the most cost-effective strategy in the primary prevention of cardiovascular disease and lead to immediate and significant improvements in population health outcomes [42, 43].”
BackgroundHealth and Economic Impacts of Eight Different Dietary Salt Reduction Interventions
Nghiem, N., Blakely, T. A., Cobiac, L. J., Pearson, A. L., & Wilson, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123915 · Cited by 78
“The Australian value is for the year 2008 (see supplementary information in Cobiac et al [23]) was derived from resource use estimates [65] and WHO unit costs (www.”
BackgroundMethodSelf-citationThe Role of Cost-Effectiveness Analysis in Developing Nutrition Policy
Cobiac, L. J., Veerman, L. J., & Vos, T. (2013) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161133 · Cited by 75
Self-citationRudnick, M. B., van Veen, J. A., & de Boer, W. (2015) · Soil Biology and Biochemistry · doi:10.1016/j.soilbio.2015.04.015 · Cited by 68
Cost-effectiveness of salt reduction to prevent hypertension and CVD: a systematic review
Schorling, E., Niebuhr, D., & Kroke, A. (2017) · Public Health Nutrition · doi:10.1017/s1368980017000593 · Cited by 74
“Markov, not dynamic LL HS QALY Salt reduction in packaged foods and in fast foods/restaurants (either mandatory or voluntary,2simulations) Salt reduction in packaged foods, fast foods/ restaurants or different food categories (either mandatory or voluntary, 18 simulations) voluntary salt reduction and labelling (35) E…”
InfluentialA systematic review of economic evaluations of population-based sodium reduction interventions
Hope, S., Webster, J. L., Trieu, K., Pillay, A. A., Ieremia, M., Bell, C., Snowdon, W., Neal, B. C., & Moodie, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173600 · Cited by 71
“…et al 2014 p p p p p p 21/23 91% Colins et al 2014 p p p p p X 19/23 83% Cobiac et al 2010 p p p p p p 23.5/24 98% Murray et al 2005 p p p p 6¼ p 19/24 79% Cobiac et al 2012 p p p p p p 22/24 92% SmithSpangler et al 2010 p p NA p p p 21/23 91% Rubinstein 2010 p p NA p 6¼ p 21/23 91% Rubenstein…”
BackgroundInfluentialSodium and Health: Old Myths and a Controversy Based on Denial
Cappuccio, F. P., Campbell, N. R. C., He, F. J., Jacobson, M. F., MacGregor, G. A., Antman, E. M., Appel, L. J., Arcand, J., Blanco‐Metzler, A., Cook, N. R., et al. (2022) · Current Nutrition Reports · doi:10.1007/s13668-021-00383-z · Cited by 66
Lara, C. A., Santos, R. O., Cadete, R. M., Ferreira, C., Marques, S., Gírio, F. M., Oliveira, E. S., Rosa, C. A., & Fonseca, C. (2014) · Antonie van Leeuwenhoek · doi:10.1007/s10482-014-0172-x · Cited by 57
Applied personality assessment in domestic dogs: Limitations and caveats
Rayment, D. J., Groef, B. D., Peters, R. A., & Marston, L. C. (2014) · Applied Animal Behaviour Science · doi:10.1016/j.applanim.2014.11.020 · Cited by 65
Calabria, B., Korda, R., Lovett, R. W., Fernando, P., Martin, T., Malamoo, L., Welsh, J., & Banks, E. (2018) · The Medical Journal of Australia · doi:10.5694/mja17.00897 · Cited by 56
Merriel, S. W. D., Andrews, V., & Salisbury, C. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.04.001 · Cited by 51
Nghiem, N., Blakely, T. A., Cobiac, L. J., Cleghorn, C., & Wilson, N. (2016) · BMC Public Health · doi:10.1186/s12889-016-3102-1 · Cited by 55
“Australia, Cobiac et al 2012 [58] Mandatory reduction of salt content in breads, margarine, and cereals; and Community Heart Health Programme (CHHP).”
BackgroundSelf-citationMartini, C. E., Tauk-Tornisielo, S. M., Codato, C. B., Bastos, R. G., & Ceccato‐Antonini, S. R. (2016) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-016-2036-1 · Cited by 46
Modeling health gains and cost savings for ten dietary salt reduction targets
Wilson, N., Nghiem, N., Eyles, H. C., Mhurchú, C. N., Shields, E., Cobiac, L. J., Cleghorn, C., & Blakely, T. A. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0161-1 · Cited by 48
“Australia, Cobiac et al 2012 [52] Mandatory reduction of salt content in breads, margarine, and cereals.”
BackgroundSelf-citation2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I. M., Backer, G. D., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0157 · Cited by 61
Faghy, M. A., Yates, J., Hills, A. P., Jayasinghe, S. U., Goulart, C. D. L., Arena, R. A., Laddu, D., Gururaj, R., Veluswamy, S. K., Dixit, S., et al. (2023) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2023.01.004 · Cited by 45
“The lingering high prevalence of CVD in Australia has led some to question the effectiveness of predominantly lifestyle-focused interventions with calls for the combination of simultaneous pharmaceutical intervention for added benefit.(141) It is also possible that greater effort should be placed on improving the tran…”
Taylor, C. B., Hoek, A. C., Deltetto, I., Peacock, A., Ha, D. T. P., Sieburg, M., Hoang, D., Trieu, K., Cobb, L. K., Jan, S., et al. (2021) · Archives of Public Health · doi:10.1186/s13690-021-00540-4 · Cited by 36
“The relationship between blood pressure and stroke/IHD was calculated based on the percentage relative risk reduction of stroke (6.3% per 1% SBP reduction) and IHD (3.4% per 1% SBP reduction) as published by Cobiac 2012 [17].”
MethodInfluentialAnderson, I. (2013) · World Bank, Washington, DC eBooks · doi:10.1596/17851 · Cited by 53
Improved PCR for identification of members of the genus Xanthomonas
Adriko, J., Mbega, E. R., Mortensen, C. N., Wulff, E. G., Tushemereirwe, W., Kubiriba, J., & Lund, O. (2013) · European Journal of Plant Pathology · doi:10.1007/s10658-013-0329-x · Cited by 30
Education to a Healthy Lifestyle Improves Symptoms and Cardiovascular Risk Factors - AsuRiesgo Study
Chaves, G., Brítez, N., Munzinger, J., Uhlmann, L., González, G., Oviedo, G., Chaparro, V., Achon, O., Bruckner, T., Kieser, M., et al. (2015) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20150021 · Cited by 34
Emmert-Fees, K. M. F., Karl, F. M., von Philipsborn, P., Rehfuess, E. A., & Laxy, M. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab028 · Cited by 29
Developing a national salt reduction strategy for Mongolia.
Enkhtungalag, B., Batjargal, J., Оchir, C., Bayandorj, T., Anderson, C. S., & Webster, J. L. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-3652.2015.04.11 · Cited by 29
“Reducing salt intake has been identified as one of the most cost-effective measures to reduce the burden of NCDs (6-10).”
BackgroundWang, G., & Bowman, B. A. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0349-1 · Cited by 27
“Using a Markov simulation model, the authors of this study [40] The authors concluded that reduction of salt in breads, margarines, and cereals is clearly the more effective and cost-effective strategy for the primary prevention of CVD; it produces larger improvements in population health, and…”
Effect of the Sugarcane Bagasse Deacetylation in the Pentoses Fermentation Process
Lima, C. S., Neitzel, T., Pereira, I. D. O., Rabelo, S. C., Ienczak, J. L., Roberto, I. C., & Rocha, G. J. M. (2021) · BioEnergy Research · doi:10.1007/s12155-020-10243-3 · Cited by 24
Webber, L., Mytton, O. T., Briggs, A. D. M., Woodcock, J., Scarborough, P., McPherson, K., & Capewell, S. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9978-0 · Cited by 31
Gao, L., Nguyen, P. K., Dunstan, D. W., & Moodie, M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16050834 · Cited by 26
“…$23,581 IHPA * Prevalent stroke $3201 Lim et al., 2005 Incident CHD $17,863 IHPA * Prevalent CHD $4539 Lim et al., 2005 Utility weight CHD 0.86 Cobiac et al., 2012 [26] Stroke 0.76 Cobiac et al., 2012 [26] * National Hospital Cost Data Collection, Independent hospital Pricing Authority (IHPA)…”
BackgroundMethodInfluentialde Souza, R. D. F. R., Dutra, E. D., Leite, F. C. B., Cadete, R. M., Rosa, C. A., Stambuk, B. U., Stamford, T. L. M., & de Morais, M. A. (2018) · 3 Biotech · doi:10.1007/s13205-018-1340-x · Cited by 23
O’Flaherty, M., Bandosz, P., Critchley, J., Capewell, S., Guzman-Castillo, M., Aspelund, T., Bennett, K., Kabir, Z., Bjorck, L. M., Bruthans, J., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.01.147 · Cited by 23
The Metagenome of Utricularia gibba's Traps: Into the Microbial Input to a Carnivorous Plant
Alcaraz, L. D., Martínez-Sánchez, S., Torres-García, I., Ibarra‐Laclette, E., & Herrera‐Estrella, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148979 · Cited by 20
McCormick, E. V., Dickinson, L. M., Haemer, M. A., Knierim, S. D., Hambidge, S. J., & Davidson, A. J. (2014) · Academic Pediatrics · doi:10.1016/j.acap.2014.06.009 · Cited by 18
Ikeda, N., Yamaguchi, M., Kashino, I., Sugiyama, T., Miura, K., & Nishi, N. (2025) · Hypertension Research · doi:10.1038/s41440-025-02108-z · Cited by 19
Aminde, L. N., Cobiac, L. J., & Veerman, L. J. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-041346 · Cited by 21
Self-citationSutton, L., Karan, A., & Mahal, A. S. (2014) · Globalization and Health · doi:10.1186/s12992-014-0079-3 · Cited by 17
“Cobiac [37] 2008 AUD Compared to ‘do nothing’: Int1 and 2 very cost-effective; Int 3 and 4 cost-effective; Int 5 not cost-effective Int1 Dominant (Dominant to Dominant); Int2 $44000/DALY averted ($19000-$100000/DALY averted); Int3 $1000000/DALY Stton et al.”
BackgroundInfluentialMcMahon, E., Webster, J. L., & Brimblecombe, J. K. (2017) · Nutrients · doi:10.3390/nu9030214 · Cited by 15
Mason, M. L. T., Matsuura, S., Domingo, A. L., Yamamoto, A., Shiro, S., Sameshima-Saito, R., & Saeki, Y. (2017) · Plant and Soil · doi:10.1007/s11104-017-3263-4 · Cited by 13
Buscemi, S., & Giordano, C. S. D. S. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.02.007 · Cited by 15
“Few studies have demonstrated that interventions at the population level aimed at ameliorating lifestyle are cost-effective [12,13], and recent European guidelines on prevention of cardiovascular disease recommend measures that promote healthy lifestyles at the population level as a class IIa indication, with a level…”
BackgroundNon-Communicable Diseases and Conditions
Tulchinsky, T. H., & Varavikova, E. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-415766-8.00005-7 · Cited by 15
Royo‐Bordonada, M. Á., Armario, P., Bejarano, J. M. L., Pedro‐Botet, J., Álvarez, F. V., Elosúa, R., Cuixart, C. B., Cortés, O., Serrano, B., Babkowski, M. C., et al. (2016) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2016.11.006 · Cited by 19
Royo‐Bordonada, M. Á., Armario, P., Bejarano, J. M. L., Pedro‐Botet, J., Álvarez, F. V., Elosúa, R., Cuixart, C. B., Cortés, O., Serrano, B., Camafort, M., et al. (2017) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2016.12.007 · Cited by 34
“Tabla 1 Prevalencia de consumo diario de refrescos en españoles de 5 a 14 años, por clase social Consumo diario ENSE 2006-7 ENSE 2011-12 % (IC95%) % n % (IC95%) % n Refrescos Alta 8,9 (7,4-10,5) 113 6,5 (4,7-8,3) 49 Media 17,7 (16,4-19,0) 601 10,8 (9,5-12,1) 233 Baja 31,7 (28,2-35,3) 210 16,7 (13,3-20,2) 76 Fuente: El…”
Peng, C., Lawson, K. D., Heffernan, M., McDonnell, G., Liew, D., Lybrand, S., Pearson, S., Cutler, H., Kritharides, L., Trieu, K., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257760 · Cited by 13
“developed an important model to assess the potential cost effectiveness of primary prevention interventions from a health sector perspective [47, 48].”
BackgroundAminde, L. N., Wanjau, M. N., Cobiac, L. J., & Veerman, L. J. (2023) · Nutrients · doi:10.3390/nu15020318 · Cited by 13
“Most modelling studies globally [13–17] and in Australia [18,19] have either focused on the impact on heart disease and stroke or did not explore the longer-term impacts on CKD [20].”
BackgroundSelf-citationSchmidt, S., Sleddens, E. F. C., de Vries, S. I., Gubbels, J. S., & Thijs, C. T. (2015) · Social Science & Medicine · doi:10.1016/j.socscimed.2015.04.018 · Cited by 11
Magnusson, R., & Patterson, D. (2015) · Asia & the Pacific Policy Studies · doi:10.1002/app5.84 · Cited by 14
Derington, C. G., Bress, A. P., Berchie, R. O., Herrick, J. S., Shen, J., Ying, J., Greene, T., Tajeu, G. S., Sakhuja, S., Ruiz‐Negrón, N., et al. (2023) · American Journal of Hypertension · doi:10.1093/ajh/hpad047 · Cited by 9
The Healthy Eating Agenda in Australia. Is Salt a Priority for Manufacturers?
Lindberg, R., Nichols, T., & Yam, C. (2017) · Nutrients · doi:10.3390/nu9080881 · Cited by 8
“Reducing salt content in processed products is one of the most cost-effective preventative population health interventions [7].”
BackgroundRoyo‐Bordonada, M. Á., Armario, P., Bejarano, J. M. L., Pedro‐Botet, J., Álvarez, F. V., Elosúa, R., Cuixart, C. B., Cortés, O., Serrano, B., Camafort, M., et al. (2017) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2016.11.012 · Cited by 15
Ikeda, N., Yamashita, H., Hattori, J., Kato, H., & Nishi, N. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1227303 · Cited by 9
Recent advances in the management of transient ischaemic attack: a clinical review
Phan, T. G., Sanders, L., & Srikanth, V. K. (2012) · Internal Medicine Journal · doi:10.1111/imj.12059 · Cited by 6
Royo‐Bordonada, M. Á., Armario, P., Bejarano, J. M. L., Pedro‐Botet, J., Alvarez, F. V., Elosúa, R., Cuixart, C. B., Cortés, O., Serrano, B., Camafort, M., et al. (2017) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2016.11.004 · Cited by 10
Parent, M. C., Davis‐Delano, L. R., Morgan, E. M., Woznicki, N. W., & Denson, A. (2019) · Gender Issues · doi:10.1007/s12147-019-09246-y · Cited by 7
Targets and indicators for chronic disease prevention in Australia
Namara, K. M., Knight, A. W., Livingston, M., Kypri, K., Malo, J., Roberts, L. M., Stanley, S., Grimes, C. A., Bolam, B., Gooey, M., et al. (2015) · Victoria University Research Repository (Victoria University) · doi:10.13140/rg.2.1.2868.1048 · Cited by 5
Wilson, N., Nghiem, N., Ryan, S., Cleghorn, C., Nair, N. P., & Blakely, T. A. (2016) · BMC Nutrition · doi:10.1186/s40795-016-0062-x · Cited by 5
“, for Argentina [9–11], Australia [12, 13], New Zealand [14] and South Africa [15]).”
BackgroundThiazide and Thiazide-Like Diuretics in Therapy of Arterial Hypertension
Orlova, Y. A., Курлыкина, Н. В., & Seredenina, E. M. (2019) · Kardiologiia · doi:10.18087/cardio.2019.11.2653 · Cited by 4
“профилактики, уступая по этому показателю только диете с ограничением употребления поваренной соли [8].”
Gao, L., Li, S., & Moodie, M. (2020) · Journal of Women s Health · doi:10.1089/jwh.2019.7995 · Cited by 5
Cardiovascular Diseases’ Awareness Among Women in Northern Jordan
Okour, A. M., Saadeh, R., Redwan, N., & Ghani, M. F. B. A. (2019) · Global Journal of Health Science · doi:10.5539/gjhs.v11n3p102 · Cited by 3
“…change in lifestyle habits and behaviors such as smoking, physical inactivity and obesity has been achieved in higher pace and magnitude, in addition to improving attendance to health care services (Cobiac et al., 2012; Ebrahim et al., 2011; Eriksson, Franks, & Eliasson, 2009; Mozaffarian, 2017).”
BackgroundInfluentialExpert opinion‐based relative landscape isolation maps for badgers across E ngland and W ales
Etherington, T. R., Trewby, I. D., WILSON, G. J., & McDonald, R. A. (2013) · Area · doi:10.1111/area.12063 · Cited by 3
Webster, J. L., & Bolam, B. (2016) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.12557 · Cited by 2
Vaz, F. L., de Souza, R. D. F. R., Dutra, E. D., Alencar, B. R. A., & Vidal, E. E. (2019) · Sugar Tech · doi:10.1007/s12355-018-0691-2 · Cited by 2
Five indicators were developed to assess the quality of reviews on preventive interventions
Allaouat, S., Roustaei, Z., Verbeek, J. H. A. M., & Ruotsalainen, J. H. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.08.017 · Cited by 2
“Because no minimal clinically important difference exists, the final decision to implement an intervention will be based on cost-effectiveness [31].”
BackgroundInfluentialInthawong, R., Khatab, K., Whitfield, M., Collins, K., Ismail, M. M., & Raheem, M. A. (2020) · OALib · doi:10.4236/oalib.1106160 · Cited by 2
Nalumansi, O. (2014) · Journal of Pharmaceutical Research International · doi:10.9734/bjpr/2014/6529 · Cited by 1
THE ECONOMIC COSTS OF NONCOMMUNICABLE DISEASES IN THE
Islands, P. (2013) · Cited by 1
$100 million to get Australia's health on track
Calder, R., Lindberg, R., & Fetherston, H. (2018) · Health Promotion Journal of Australia · doi:10.1002/hpja.62 · Cited by 1
Gao, L., & Moodie, M. (2022) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-022-01384-z · Cited by 1
“Since this economic evaluation is based on modelling without primary data collection, the cost of providing a lifestyle modification program was calculated based on a previous study [26], and included the following components:”
BackgroundMethodMensah, J. P., Thomas, C., Akparibo, R., & Brennan, A. (2025) · BMC Public Health · doi:10.1186/s12889-024-21237-7 · Cited by 2
Dhungel, B., Grimshaw, S., Wilson, T. E., Fox, L., Breadon, P., Trieu, K., Neal, B. C., & Blakely, T. A. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.10.009 · Cited by 1
Value-for-money and the small charity
Evans, C., & Weller, S. (2022) · Public Money & Management · doi:10.1080/09540962.2022.2047287 · Cited by 2
“Despite the academic interest in VFM across a range of broad sectors, especially health (Cobiac et al., 2012; Turner-Stokes, 2007) and the public sector (Dimitri, 2013; Marinelli & Antoniou, 2019), it seems that a universal model or framework for VFM that could be embraced by the charity sector has…”
BackgroundKhatab, K., Inthavong, R., Whitfield, M., Collins, K., Ismail, M. M., & Raheem, M. A. (2020) · Preprints.org · doi:10.20944/preprints202001.0162.v1 · Cited by 1
“Many studies in the health economics field have investigated the cost-effectiveness of secondary prevention programs and treatment strategies, such as comparing the multidrug regimen for prevention of CVD [16]-[20], coronary artery revascularization procedures [21], and the treatment of high blood pressure [22].”
BackgroundEthnicity and cardiovascular disease prevention
Baker, J. (2015) · Enlighten: Theses (The University of Glasgow)
Andrew, N. E., Hankey, G. J., & Cadilhac, D. A.-M. (2014) · Future Neurology · doi:10.2217/fnl.14.30 · Cited by 1
The Value Proposition for Prevention and Screening
Ballard, D., da Graca, B., Fleming, N., & Fullerton, C. (2015) · Productivity Press eBooks · doi:10.1201/b19266-7
Williams, P. (2015) · Productivity Press eBooks · doi:10.1201/b19266-10
Executive Function and Complex Processing Models
Williams, D. L. (2018) · Wiley eBooks · doi:10.1002/9781119158431.ch3
The Health Gains and Cost Savings of Eradicating Cold Housing in AustraliaPreprint
Mishra, S. R., Wilson, T. E., Andrabi, H., Ouakrim, D. A., Li, A., Singh, A., Akpan, E., Bentley, R., & Blakely, T. A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4165606
Noncommunicable diseases and conditions
Tulchinsky, T. H., Varavikova, E. A., & Cohen, M. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822957-6.00014-4 · Cited by 1
Taylor, C. B., Hoek, A. C., Deltetto, I., Peacock, A., Phuong, H. D. T., Sieburg, M., Hoang, D., Trieu, K., Cobb, L. K., Jan, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14205161
Metadata
- Authors
- Cobiac, L. J., Magnus, A., Lim, S., Barendregt, J. J., Carter, R., & Vos, T.
- Affiliations
- The University of Queensland (AU)
- Deakin University (AU)
- Institute for Health Metrics and Evaluation (US)
- Corresponding author
- Cobiac, Linda J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-07-23
- Volume
- 7
- Issue
- 7
- Pages
- e41842
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3402472
- OpenAlex
- W2010609873
- Cited by
- 97
- References
- 60
- Citations by year
- 2025: 3 · 2023: 5 · 2022: 4 · 2021: 5 · 2020: 4 · 2019: 8 · 2018: 5 · 2017: 16 · 2016: 14 · 2015: 11 · 2014: 11 · 2013: 7 · 2012: 3
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Griffith Research Online (submittedVersion, cc-by)
- Funders
- Medical Research Council
- National Health and Medical Research Council (351558)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- cardiovascular disease prevention, primary prevention, cost-effectiveness, statins, lifestyle intervention, ischemic heart disease, stroke, diuretics, calcium channel blockers, ACE inhibitors, health care costs, Australia
- MeSH terms
- Adult, Aged, Aged, 80 and over, Blood Pressure, Cardiovascular Diseases, Cholesterol, Cost-Benefit Analysis, Female, Humans, Life Style, Male, Middle Aged, Primary Prevention, Health Care Sector
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.